NCT07842133

Brief Summary

This study aims to evaluate the effects of progressive muscle relaxation exercises on fatigue, dyspnea, and respiratory function in patients with systemic sclerosis. Participants will be assessed before and after the intervention.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
3mo left

Started Apr 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress66%
Apr 2026Dec 2026

Study Start

First participant enrolled

April 25, 2026

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

September 20, 2026

Completed
5 days until next milestone

First Posted

Study publicly available on registry

September 25, 2026

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 10, 2026

Expected
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 25, 2026

Last Updated

September 25, 2026

Status Verified

September 1, 2026

Enrollment Period

7 months

First QC Date

September 20, 2026

Last Update Submit

September 20, 2026

Conditions

Keywords

Systemic sclerosis; Scleroderma; Progressive muscle relaxation; Fatigue; Dyspnea; Respiratory function; Relaxation exercise

Outcome Measures

Primary Outcomes (3)

  • Respiratory function measured by forced expiratory volume in 1 second (FEV1) and forced vital capacity (FVC)

    Respiratory function will be assessed using spirometry, including forced expiratory volume in 1 second (FEV1) and forced vital capacity (FVC). Changes in FEV1 and FVC from baseline to post-intervention assessment will be evaluated between the intervention and control groups.

    Baseline and 4 weeks after the intervention

  • Fatigue severity measured by the FACIT-Fatigue Scale

    Fatigue will be assessed using the Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-Fatigue) Scale. Changes in fatigue scores from baseline to post-intervention assessment will be evaluated between the intervention and control groups.

    Baseline and 4 weeks after the intervention

  • Dyspnea severity measured by the Dyspnea-12 (D-12) Scale

    Dyspnea will be assessed using the Dyspnea-12 (D-12) Scale. Changes in dyspnea scores from baseline to post-intervention assessment will be evaluated between the intervention and control groups.

    Baseline and 4 weeks after the intervention

Study Arms (2)

Progressive Muscle Relaxation Exercise Group

EXPERIMENTAL

Participants randomly assigned to this group will receive progressive muscle relaxation exercises in addition to standard care.

Behavioral: Progressive Muscle Relaxation Exercise

Control Group

NO INTERVENTION

Participants randomly assigned to this group will receive standard care without progressive muscle relaxation exercises.

Interventions

Participants in the intervention group will receive progressive muscle relaxation exercises according to the study protocol. The intervention will be administered in addition to standard care.

Progressive Muscle Relaxation Exercise Group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Gaziantep University Vocational School of Health Services

Gaziantep, Şehitkamil, 27000, Turkey (Türkiye)

RECRUITING

Related Publications (2)

  • Fairley JL, Hansen D, Proudman S, Baron M, Sahhar J, Ngian GS, Walker J, Host LV, Morrisroe K, Stevens W, Ross L, Nikpour M. The burden and determinants of fatigue in incident and prevalent systemic sclerosis. Clin Exp Rheumatol. 2024 Aug;42(8):1669-1674. doi: 10.55563/clinexprheumatol/6528od. Epub 2024 Aug 14.

  • Yakut H, Ozalevli S, Birlik AM. Fatigue and its relationship with disease-related factors in patients with systemic sclerosis: A cross-sectional study. Turk J Med Sci. 2021 Apr 30;51(2):530-539. doi: 10.3906/sag-2005-314.

MeSH Terms

Conditions

Scleroderma, SystemicScleroderma, DiffuseFatigueDyspneaRespiratory Aspiration

Condition Hierarchy (Ancestors)

Connective Tissue DiseasesSkin and Connective Tissue DiseasesSkin DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsRespiration DisordersRespiratory Tract DiseasesSigns and Symptoms, RespiratoryPathologic Processes

Study Officials

  • Adile Neşe, Associate Professor

    University of Gaziantep

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Adile Neşe, Assoc Prof.

CONTACT

Adile Neşe, Assoc Prof

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Masking Details
Participants and outcome assessors are blinded to group allocation. The researcher administering the intervention is aware of the group allocation.
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: Participants will be randomly assigned to either the progressive muscle relaxation exercise group or the control group. The intervention group will receive progressive muscle relaxation exercises, while the control group will receive standard care. Outcomes will be assessed and compared between the two groups before and after the intervention.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

September 20, 2026

First Posted

September 25, 2026

Study Start

April 25, 2026

Primary Completion (Estimated)

November 10, 2026

Study Completion (Estimated)

December 25, 2026

Last Updated

September 25, 2026

Record last verified: 2026-09

Data Sharing

IPD Sharing
Will not share

Individual participant data will not be shared with other researchers. Data will be used only for the purposes of this study and will be handled in accordance with applicable ethical and data protection requirements.

Locations